Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Capcium Inc. announced today that the companies have signed a strategic agreement to produce high quality cannabis-based softgels for patients. Additionally, Aurora has acquired a 19.99% ownership interest in Capcium by way of a non-brokered private placement for consideration of $10 million.
Articles
TerrAscend and Cistron Launch Ascendant Laboratories
TerrAscend Corp. (CSE: TER) is pleased to announce the formation of a strategic joint venture with Cistron Corp. with the launch of Ascendant Laboratories Inc., a science and innovation company dedicated to the advancement of cannabinoid expressing plant biology. Ascendant Laboratories brings together leaders in plant sciences and cannabis production, with a unified vision of elevating the cannabis industry through the development of advanced plant genetics.
Aphria to build state-of-the art Extraction Centre of Excellence
Aphria Inc. (TSX: APH and US OTC: APHQF) today announced that the company's Board of Directors approved a $55 million capital project to build a state-of-the-art Extraction Centre of Excellence in Leamington, ON.
MedMen Announces Acquisition of Florida Marijuana License and Cultivation Facility
MedMen Enterprises Inc. (CSE: MMEN), the country’s leading cultivator, producer and retailer of state-sanctioned cannabis, today announced that it has signed a definitive agreement to acquire dispensary and cultivation assets from Florida based Treadwell Simpson Partnership and affiliates.
CannTrust Holdings Inc. Announces Closing of $100,395,000 Bought Deal Financing
CannTrust Holdings Inc. (TSX: TRST), a licensed producer of medical cannabis under the Health Canada Access to Cannabis for Medical Purposes Regulation program, today announced that it has closed its previously announced short form prospectus offering, on a bought deal basis, including the full exercise of the over-allotment option. A total of 11,155,000 units of the Company were sold at a price of $9.00 per Unit for aggregate gross proceeds of $100,395,000.
Organigram Announces Health Canada Licensing of Phase 3 Cultivation Expansion
Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQB: OGRMF) a leading licensed producer of medical marijuana based in Moncton, New Brunswick, is pleased to announce that it has received an expanded cultivation license from Health Canada related to its previously announced Phase 3 expansion.
Organigram Enters into Non-Binding Term Sheet for 26% Equity Interest in Eviana Health Corporation
Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQB: OGRMF) and Eviana Health Corporation (CSE: EHC) (OTC: EVNNF) are pleased to jointly announce that the Companies have entered into a non-binding term sheet whereby Organigram will make a significant equity investment into Eviana.
Saskatchewan Announces Cannabis Retailers
Big news today as the Province of Saskatchewan announced the recipients of permits for the 51 Cannabis Retail Stores in the province.
Entrepreneur.com: New Numbers Reveal the Marijuana Industry Boom Has Only Just Begun
Sales of both recreational and medical marijuana already reach far into the billions with vast new markets set to open soon.
Canopy Rivers Announces Board of Directors and Key Additions to Management Team
Canopy Rivers Corporation is pleased to announce its newly appointed, majority independent Board of Directors, as well as a number of strategic appointments to its management team.
Cannabis Wheaton Announces Closing of $115 Million Bought Deal Financing and Exercise in Full of Underwriters’ Over-Allotment Option
Cannabis Wheaton Income Corp. (TSX.V:CBW) is pleased to announce the closing of its previously announced bought deal public offering of 82,225,000 units of the Company, which includes the full exercise of the over-allotment option granted to the underwriters, at a price of C$1.40 per Unit for gross proceeds of $115,115,000.
Liberty Health Sciences to be exclusive distributor of Isodiol International products throughout Florida and Massachusetts
Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) is pleased to announce that it has signed a licensing agreement with Isodiol International Inc., a leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of CBD consumer products, to provide a complementary suite of medical cannabis products to patients in Florida and Massachusetts.
Aurora Cannabis Launches New Cannabis Product Line - Aurora Frost
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announces the launch of new product line called Aurora Frost. This new dried cannabis product line represents the highest potency offering of any Aurora product launched to date at over 35% THC.
Canopy Growth Corporation announces entry into the African market with acquisition of Daddy Cann Lesotho
Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) is pleased to announce that the Company has acquired Daddy Cann Lesotho PTY Ltd., trading as Highlands.
Harvest One announces Aldergrove BC Expansion site
Harvest One Cannabis Inc. (TSXV: HVT) is pleased to advise that its wholly owned subsidiary, United Greeneries, has entered into a five-year lease agreement, with three five year renewal options, for a lower mainland site that will meet all previous announced capacity targets.
